To determine the correlation between SFRP1/β-catenin expression and occurrence of PCa, the protein expression of SFRP1 and β-catenin in benign prostatic hyperplasia and prostate tumor samples were compared by immunohistochemistry (Fig. 2). Here, SFRP1 is linked to prostate neoplasm.